Immune-Onc Therapeutics Announces FDA Clearance of IND Application to Initiate First-In-Human Trial of IO-108, a Novel Antagonist Antibody Targeting LILRB2 Thumbnail Image Read more about Immune-Onc Therapeutics Announces FDA Clearance of IND Application to Initiate First-In-Human Trial of IO-108, a Novel Antagonist Antibody Targeting LILRB2
Dr. Akihide Yoshimi: 2020 CDP Achievement Award Winner Read more about Dr. Akihide Yoshimi: 2020 CDP Achievement Award Winner
Dr. Matthew Witkowski: 2020 CDP Achievement Award Winner Read more about Dr. Matthew Witkowski: 2020 CDP Achievement Award Winner
Dr. Daniel Starczynowski: 2020 CDP Achievement Award Winner Read more about Dr. Daniel Starczynowski: 2020 CDP Achievement Award Winner
Dr. Ravi Majeti: 2020 CDP Achievement Award Winner Read more about Dr. Ravi Majeti: 2020 CDP Achievement Award Winner
Exciting new publications supported by LLS: Summer 2021 edition Thumbnail Image Read more about Exciting new publications supported by LLS: Summer 2021 edition
Caribou Biosciences Announces Closing of Upsized Initial Public Offering Thumbnail Image Read more about Caribou Biosciences Announces Closing of Upsized Initial Public Offering
Mantle Cell Lymphoma Research Initiative II (MCL2) Thumbnail Image Read more about Mantle Cell Lymphoma Research Initiative II (MCL2)
